TGA approves pathway for more plasma donors

30 May 2023 - The Government welcomes the Therapeutic Goods Administration’s approval of a ‘plasma pathway’, allowing a larger pool of ...

Read more →

TGA approves Grifols' Xembify

15 July 2022 -  Xembify is yet another presentation of human immunoglobulin. ...

Read more →

TGA approves Octapharma's Cutaquig

12 May 2021 - The TGA has deemed it to be a new biological entity. Others will beg to differ. ...

Read more →

CSL Behring Australia commences development of treatment for serious cases of COVID-19

6 May 2020 - Plasma-derived therapeutic with potential to treat serious complications of COVID-19. ...

Read more →

COVID-19: potentially life saving immunoglobulin treatment for seriously ill Australians

6 May 2020 - The Australian Government welcomes the announcement by CSL Behring that Australia will be one of the first ...

Read more →

CSL ramps up development of COVID-19 plasma treatment

6 May 2020 - Australia’s biggest health company CSL has confirmed it will immediately begin development of plasma-derived therapy to ...

Read more →

Cows come home for CSL in COVID-19 vaccine battle

8 April 2020 - It sounds like a pitch for a sci-fi thriller — using genetically modified cows to fight ...

Read more →

CSL to fight patent infringement claim from US based Bioverativ

10 July 2017 - Australian vaccines and blood products developer CSL says it will vigorously fight a patent infringement claim ...

Read more →

Therapeutic Goods Administration approves Afstyla - CSL Behring's novel recombinant haemophilia A treatment

19 April 2017 - In clinical trials, patients undergoing prophylaxis with Afstyla experienced a median annualised spontaneous bleeding rate of ...

Read more →

TGA approves Grifols' Prolastin C

17 November 2016 - The TGA has approved Grifols' new alfa-1-proteinase inhibitor. ...

Read more →

Idelvion now registered in Australia

27 September 2016 - CSL Behring's Idelvion is now approved by the TGA. ...

Read more →

TGA approves new indication for Alprolix

15 September 2016 - The TGA has approved a new use for Biogen's Alprolix. ...

Read more →

TGA publishes AusPAR for simoctocog alfa rhu (Nuwiq)

17 June 2016 - The TGA has published an AusPAR for Octapharma's Nuwiq (simoctocog alfa). ...

Read more →

April 2016 NCE registrations - TGA

2 May 2016 - The TGA registered two new chemical entities (medicines) and two new blood products in April 2016. ...

Read more →